Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants

Bibliographic Details
Main Authors:	Bosco Paes, Marcello Lanari, Barry Rodgers-Gray, John Fullarton, Xavier Carbonell-Estrany
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Pediatrics
Subjects:	respiratory syncytial virus risk factors pediatric hospitalization passive immunoprophylaxis preterm infants
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2024.1343960/full

Internet